Vera Therapeutics, Inc.

VERA chart

Vera Therapeutics, Inc. news

• Raymond James reiterates Vera Therapeutics stock Strong Buy on kidney disease data

  Investing.com Australia · Oct 26, 4:02 PM EDT

• Vera Therapeutics, Inc. Estimates – NASDAQ:VERA

  TradingView · Oct 25, 5:50 PM EDT

• Vera Therapeutics (VERA) Stock Dropped, So What Is Behind The Move?

  Simply Wall Street · Oct 25, 11:55 AM EDT

• Understanding Momentum Shifts in (VERA)

  Stock Traders Daily · Oct 25, 12:20 AM EDT

• Vera (VERA) Stock: Steady at $28.91, Support at $27.46 2026-10-23 - Sector Sentiment

  https://www.siam.in/ · Oct 23, 1:34 PM EDT

• Is Phase III Kidney Disease Data Altering The Investment Case For Vera Therapeutics (VERA)?

  Simply Wall Street · Oct 23, 9:56 AM EDT

• Cantor Fitzgerald reiterates Vera Therapeutics stock rating on kidney drug data

  Investing.com · Oct 23, 9:00 AM EDT

• Guggenheim Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $76

  Moomoo · Oct 23, 8:34 AM EDT

• Vera Therapeutics (VERA) Institutional Ownership 2026

  MarketBeat · Oct 23, 3:00 AM EDT

• Vera Therapeutics' TRUTAKNA Delivers Strong Phase III IgA Nephropathy Results

  marketbeat.com · Oct 22, 9:04 PM EDT

• Vera Therapeutics plans FDA filing for IgAN drug in Q4 2026

  Investing.com · Oct 22, 10:50 AM EDT

• Vera Therapeutics ORIGIN 3 trial meets all endpoints for IgAN drug

  StreetInsider · Oct 22, 10:09 AM EDT

Vera Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-09-15
• 10-Q10-Q2026-08-10
• 8-K8-K2026-08-10
• 8-K8-K2026-07-09
• 8-K8-K2026-07-07
• 8-K8-K2026-06-02
• 8-K8-K2026-05-26
• 10-Q10-Q2026-05-07
• 8-K8-K2026-05-07
• DEF 14ADEF 14A2026-04-09
• 8-K8-K2026-03-09
• 10-K10-K2026-02-26

About Vera Therapeutics, Inc.

Ticker

VERA (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Brisbane, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1831828

Frequently asked questions